Abstract
Objective
Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor. The present study is aimed to compare the serum level of adipokines in patients with MG with that in controls, as well as to study the relation of these levels with disease severity.
Patients and methods
Fifty patients with MG and 30 healthy individuals were enrolled in our study. Serum concentrations of select adipokines, namely adiponectin, leptin, omentin, visfatin, and resistin were measured.
Results
The results showed a significant increase in serum concentrations of adiponectin and resistin in the patients with MG compared with the controls.
Conclusion
Further studies are warranted to assess changes in adipokine concentration levels in patients with MG.
Keywords:
Acknowledgments
This study was supported by the Medical University of Silesia.
Disclosure
The authors report no conflicts of interest in this work.